A mathematical model that predicts how antibodies made by COVID-19 vaccines protect against symptomatic infections has been developed by scientists at the Indian Institute of Science (IISc) and the Queensland Brain Institute (QBI) in Australia.

A paper about the study was published in Nature Computational Science.